clasto-lactacystin beta-lactone and gw 6471

clasto-lactacystin beta-lactone has been researched along with gw 6471 in 1 studies

Compound Research Comparison

Studies (clasto-lactacystin beta-lactone)	Trials (clasto-lactacystin beta-lactone)	Recent Studies (post-2010) (clasto-lactacystin beta-lactone)	Studies (gw 6471)	Trials (gw 6471)	Recent Studies (post-2010) (gw 6471)
85	0	15	74	0	66

Protein Interaction Comparison

Protein	Taxonomy	clasto-lactacystin beta-lactone (IC50)	gw 6471 (IC50)
Chain A, PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR	Homo sapiens (human)		0.24
Peroxisome proliferator-activated receptor alpha	Homo sapiens (human)		0.24

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cai, J; Lin, B; Qu, J; Snider, BJ; Sun, L; Wu, M; Wu, S	1

Other Studies

1 other study(ies) available for clasto-lactacystin beta-lactone and gw 6471

Article	Year
Pretreatment with proteasome inhibitors protects against oxidative injuries via PPARα-dependent and -independent pathways in ARPE-19 cells. Investigative ophthalmology & visual science, 2012, Aug-31, Volume: 53, Issue:9 Topics: Aldehydes; Anilides; Cells, Cultured; Cysteine Proteinase Inhibitors; Electrophoretic Mobility Shift Assay; Humans; Lactones; Leupeptins; Oxazoles; Oxidative Stress; PPAR alpha; Retinal Pigment Epithelium; Tyrosine; Vitamin K 3	2012

Article

Year

Pretreatment with proteasome inhibitors protects against oxidative injuries via PPARα-dependent and -independent pathways in ARPE-19 cells.

Investigative ophthalmology & visual science, 2012, Aug-31, Volume: 53, Issue:9

Topics: Aldehydes; Anilides; Cells, Cultured; Cysteine Proteinase Inhibitors; Electrophoretic Mobility Shift Assay; Humans; Lactones; Leupeptins; Oxazoles; Oxidative Stress; PPAR alpha; Retinal Pigment Epithelium; Tyrosine; Vitamin K 3

2012